Baker Norton (Zhejiang) Pharmaceutical

Zhejiang Baker Norton Pharmaceutical is a prominent pharmaceutical company based in Hangzhou, China, specializing in the development, manufacturing, and marketing of anti-infectives, respiratory treatments, and pediatric medicines. Established in 1989 as a joint venture between Teva Pharmaceutical Industries and Zhejiang Pharmaceutical Co., Ltd., it was one of the first Sino-foreign pharmaceutical joint ventures in China. The company is widely recognized for its high-quality production of amoxicillin/clavulanate potassium and salbutamol sulfate, adhering to international GMP standards. In 2017, Zhejiang Pharmaceutical acquired Teva's stake, making the company a key subsidiary within its group. Baker Norton (Zhejiang) continues to leverage its historical international expertise to maintain a strong presence in the Chinese domestic healthcare market.